AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Faster, Easier Cures for Hepatitis C

ucm405643

Transformative advances in drug treatments approved by the Food and Drug Administration are giving the 3.2 million Americans with chronic hepatitis C a chance for a longer, healthier life without the virus. That’s welcome news for baby boomers—who make up three of four adults with the hepatitis C virus—and millions of other Americans, many of…

NIH’s Dr. Carl Dieffenbach Shares Final Thoughts from AIDS 2014

aids2014

As the 20th International AIDS Conference (AIDS 2014) drew to a close in Melbourne, Australia, we asked Dr. Carl Dieffenbach from NIH/NIAIDto provide a summary of conference highlights. Dr. Dieffenbach recognized the Malaysia Airlines tragedy, a loss deeply felt by those in the worldwide HIV community. He noted that the conference theme of “stepping up…

NIH’s Dr. Gina Brown Reflects on HIV Among Women and Girls –Highlights from AIDS 2014

gina_brown

Addressing HIV/AIDS among women and girls was a key focus area of many sessions at the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia. Presenters covered such important topics as HIV prevention interventions for women and girls, the prevention of mother-to-child transmission, and enhancing HIV care and treatment for women and girls. To learn…

NIH’s Dr. Carl Dieffenbach Shares Highlights from Thursday at AIDS 2014

carl

At the conclusion of Thursday’s sessions at the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia, we spoke again with Dr. Carl Dieffenbach from NIH/NIAID to hear his summary of conference highlights of the day. Dr. Dieffenbach observed that much of the conversation on Thursday was around advances in HIV prevention and how to optimize…

NIH’s Dr. Carl Dieffenbach Shares Highlights from Wednesday at AIDS 2014

clinton_2014

At the conclusion of another science-filled day at the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia, we caught up again with Dr. Carl Dieffenbach from NIH/NIAID to hear about what he thought were highlights of the day. He pointed, first, to the address by former President Bill Clinton who spoke about the work of the Clinton…

NIH’s Dr. Carl Dieffenbach Shares a Highlight from Day 3 of AIDS 2014 on Making Better, Smarter Investments to Achieve AIDS-Free Generation

dybul

This week, we’ve asked Dr. Carl Dieffenbach from NIH/NIAID to share daily science highlights from the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia. His highlight today was a presentation by Ambassador Mark Dybul, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, about how better and smarter investments can bring…

AIDS 2014 Day 3: CDC’s Laura Kann on Adolescents and HIV-Related Risk Behavior

kann

Dr. Laura Kann, head of the School-Based Surveillance Branch in CDC’s Division of Adolescent and School Health, is attending AIDS 2014 to present a study entitled “Unequal Progress and Cause for Concern: Differences in HIV-Related Risk Behavior Trends Among Subgroups of Adolescents, 1991-2013” . The study, which is based on data from the CDC’s National…

NIH’s Dr. Carl Dieffenbach Shares Science Highlight from Second Day of AIDS 2014

fauci_special_session

The second day of the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia was filled with scientific findings shared by researchers from around the world. We caught up again with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), and asked him to reflect…

Page 1 of 211234...1020...Last »